Last Price$222.71.6%
Market Cap$21.9B
LTM Return on Capital Employed (ROCE)
8.4%
5Y avg
5.7%
Medical - Devices industry
median
(19.5%)
Stock quality & Intrinsic value
6/10
(0.1%) overvalued
STERIS plc Return on Capital Employed (ROCE)
Annual
Quarterly
LTM
Industry median
Company stand-alone
Crunching data... Almost there!
| Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Capital Employed (ROCE) | 9.7% | 6.7% | 8.8% | 8.1% | 11.8% | 13.7% | 5.9% | 13.3% | 13.2% | 9.3% | 8.9% | 4.5% | 3.2% | 7.3% | 7.4% | 5.3% | 3.7% | 4.3% | 2.1% | 6.8% |
Overvalued or undervalued?
Check the intrinsic value for STE
and see if it's the right time to invest.
STERIS plc (STE) Return on Capital Employed (ROCE) comparison analysis
General
LTM Return on Capital Employed (ROCE)
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
STERIS plcSTE
8.4%
3.6%
257.9%
7.4%
Median Peer Set
9.9%
5.6%
72.0%
12.7%
Abbott LaboratoriesABT
21.0%
4.6%
134.5%
31.9%
Insulet CorporationPODD
17.7%
30.0%
4,364.6%
12.2%
Edwards Lifesciences CorporationEW
14.3%
(9.4%)
202.2%
76.7%
DexCom, Inc.DXCM
11.4%
11.3%
(1.4%)
14.3%
Align Technology, Inc.ALGN
10.6%
3.4%
26.0%
11.5%
Stryker CorporationSYK
9.2%
10.2%
(5.8%)
13.2%
Boston Scientific CorporationBSX
7.4%
17.6%
16.7%
11.1%
Medtronic plcMDT
6.6%
3.6%
(2.1%)
11.4%
Zimmer Biomet Holdings, Inc.ZBH
4.5%
6.5%
253.2%
13.8%
Koninklijke Philips N.V.PHG
(4.2%)
(0.8%)
118.1%
(3.9%)
STE key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 1,119.7 3.0% | 1,160.3 3.6% | 1,197.4 3.2% | 1,265.1 5.7% | 1,298.5 2.6% | 1,257.7 (3.1%) | 1,207.4 (4.0%) | 1,391.5 15.2% | 1,501.9 7.9% | 1,622.3 8.0% | 1,850.3 14.1% | 2,238.8 21.0% | 2,612.8 16.7% | 2,620.0 0.3% | 2,782.2 6.2% | 3,030.9 8.9% | 3,107.5 2.5% | 4,585.1 47.5% | 4,957.8 8.1% | 5,138.7 3.6% |
| Cost of Goods Sold (COGS) | 648.1 | 676.1 | 692.6 | 741.1 | 771.8 | 718.6 | 761.3 | 823.0 | 880.6 | 972.6 | 1,076.0 | 1,343.3 | 1,587.1 | 1,525.8 | 1,606.7 | 1,711.0 | 1,764.4 | 2,568.7 | 2,798.1 | 2,920.5 |
% margin | 471.7 42.1% | 484.2 41.7% | 504.8 42.2% | 524.0 41.4% | 526.7 40.6% | 539.2 42.9% | 446.2 37.0% | 568.5 40.9% | 621.3 41.4% | 649.6 40.0% | 774.3 41.8% | 895.5 40.0% | 1,025.6 39.3% | 1,094.2 41.8% | 1,175.4 42.2% | 1,319.9 43.5% | 1,343.1 43.2% | 2,016.4 44.0% | 2,159.7 43.6% | 2,218.2 43.2% |
| Operating Expenses | 326.7 | 349.2 | 360.5 | 385.0 | 347.7 | 330.6 | 359.7 | 345.5 | 395.8 | 429.6 | 547.5 | 683.4 | 739.5 | 690.7 | 733.0 | 782.3 | 797.6 | 1,590.7 | 1,400.5 | 1,382.0 |
| Research & Development Expenses (R&D) | 35.5 | 33.6 | 33.6 | 36.9 | 32.8 | 34.0 | 34.3 | 36.0 | 41.3 | 48.6 | 54.1 | 56.7 | 59.4 | 60.8 | 63.0 | 65.5 | 66.3 | 87.9 | 101.6 | 103.7 |
| Selling, General & Administrative Expenses (SG&A) | 291.1 | 315.6 | 326.9 | 348.0 | 315.0 | 296.6 | 325.5 | 309.6 | 354.5 | 381.0 | 493.3 | 626.7 | 680.1 | 629.9 | 669.9 | 716.7 | 731.3 | 1,502.8 | 1,298.9 | 1,252.3 |
% margin | 145.0 12.9% | 109.7 9.5% | 137.7 11.5% | 123.5 9.8% | 175.4 13.5% | 203.7 16.2% | 85.2 7.1% | 222.3 16.0% | 242.8 16.2% | 206.8 12.7% | 227.2 12.3% | 212.9 9.5% | 227.6 8.7% | 403.5 15.4% | 411.5 14.8% | 341.1 11.3% | 323.3 10.4% | 425.6 9.3% | 268.2 5.4% | 836.1 16.3% |
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 1.6 | 1.3 | 0.6 | 0.9 | 0.0 | 0.3 | 0.8 | 1.7 | 1.6 | 2.2 | 3.0 | 2.0 | 6.3 | 6.3 | 108.0 | 11.0 |
| Interest Expense | 3.1 | 44.9 | 16.9 | 34.7 | 10.6 | 13.2 | 12.0 | 12.1 | 15.7 | 18.8 | 19.2 | 42.7 | 44.5 | 50.6 | 45.0 | 40.3 | 37.2 | 89.6 | 109.6 | 144.4 |
| Pre-tax Income | 141.9 | 108.1 | 132.9 | 119.8 | 166.5 | 191.8 | 73.8 | 211.1 | 227.1 | 188.4 | 208.8 | 171.9 | 184.6 | 355.0 | 369.5 | 498.7 | 517.5 | 314.5 | 157.3 | 702.8 |
% effective tax rate | 56.0 39.4% | 45.2 41.8% | 51.8 39.0% | 42.7 35.6% | 55.8 33.5% | 63.3 33.0% | 22.6 30.6% | 75.0 35.5% | 67.1 29.6% | 58.9 31.3% | 73.8 35.3% | 60.3 35.1% | 74.0 40.1% | 63.4 17.8% | 64.4 17.4% | 90.9 18.2% | 120.7 23.3% | 71.6 22.8% | 51.5 32.8% | 149.5 21.3% |
% margin | 86.0 7.7% | 70.3 6.1% | 82.2 6.9% | 77.1 6.1% | 110.7 8.5% | 128.5 10.2% | 51.3 4.2% | 136.1 9.8% | 160.0 10.7% | 129.4 8.0% | 135.1 7.3% | 110.8 4.9% | 110.0 4.2% | 290.9 11.1% | 304.1 10.9% | 407.7 13.5% | 397.4 12.8% | 243.9 5.3% | 107.0 2.2% | 378.2 7.4% |
| EPS | 1.24 | 1.03 | 1.26 | 1.22 | 1.88 | 2.18 | 0.86 | 2.33 | 2.74 | 2.20 | 2.27 | 1.57 | 1.29 | 3.42 | 3.59 | 4.81 | 4.66 | 2.50 | 1.07 | 3.83 |
| Diluted EPS | 1.23 | 1.02 | 1.25 | 1.20 | 1.86 | 2.16 | 0.85 | 2.31 | 2.72 | 2.17 | 2.25 | 1.56 | 1.28 | 3.39 | 3.56 | 4.76 | 4.63 | 2.48 | 1.07 | 3.81 |
% margin | 196.2 17.5% | 171.0 14.7% | 200.4 16.7% | 188.6 14.9% | 235.8 18.2% | 261.2 20.8% | 140.4 11.6% | 286.1 20.6% | 294.5 19.6% | 303.8 18.7% | 319.5 17.3% | 438.7 19.6% | 503.0 19.3% | 594.5 22.7% | 693.1 24.9% | 743.2 24.5% | 800.3 25.8% | 957.2 20.9% | 1,344.0 27.1% | 1,412.4 27.5% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is STERIS plc's Return on Capital Employed (ROCE)?
As of today, Microsoft Corp's last 12-month Return on Capital Employed (ROCE) is 8.4%, based on the financial report for Dec 31, 2024 (Q4’2024). The average annual Return on Capital Employed (ROCE) for STERIS plc have been 4.6% over the past three years, and 6.0% over the past five years.
2) Is STERIS plc's Return on Capital Employed (ROCE) Good?
As of today, STERIS plc's Return on Capital Employed (ROCE) is 8.4%, which is higher than industry median of (19.5%). It indicates that STERIS plc's Return on Capital Employed (ROCE) is Good.